ONTX Onconova Therapeutics Inc

Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule drug candidates to treat cancer. The Company has three clinical-stage product candidates and six preclinical programs.

$3.00
As of 11/30/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/25/2013
Outstanding shares:  21,531,040
Average volume:  390,760
Market cap:   $68,253,397
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68232V801
ISIN:        US68232V8019
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -3.49
PB ratio:   1.28
PS ratio:   300.68
Return on equity:   -24.98%
Net income %:   -5,464.95%